Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	-11.54	34.15	38.60
Graham Fair Price	1.08	17391.66	17206.00
PEG	11208.46	0.22	< 0.005
Price/Book	18.69	0.29	0.25
Price/Cash Flow	-37.23	1.75	2.78
Prices/Earnings	6.28	1.57	1.48
Price/Sales	2.25	0.52	0.51
Price/FCF	-37.23	1.75	2.78
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	0.00	1.00	1.00
Operating Margin	48.54	< 0.005	< 0.005
ROA	1.29	< 0.005	< 0.005
ROE	0.04	0.05	11.68
ROIC	< 0.005	< 0.005	94.46
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	-0.01	< 0.005	-52.35
Dividends QOQ	-1.00	< 0.005	-99.63
EBIT QOQ	1.00	0.64	-35.77
EPS QOQ	7.48	0.07	-99.06
FCF QOQ	-0.61	0.80	30.66
Revenue QOQ	0.02	0.11	377.28
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	0.00	0.00	0.00
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.16	0.17	3.98
Quick Ratio	0.02	8.55	44818.81
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	17714.68	17610.40	-0.59
Cash	1660.96	2104.87	26.73
Capex	-31.38	697.10	2121.22
Free Cash Flow	1581.98	2861.07	80.85
Revenue	8610.43	9559.48	11.02
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	0.04	8.55	19829.10
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	12.55	8.43	-32.79
Naive Interpretation	Member

06 - Financial Health · Bad

Rating